Staphylococcus Aureus antibody (Biotin)

Catalog No. ABIN111568

Product Details anti-Staphylococcus Aureus Antibody (Biotin)

Target: Staphylococcus Aureus

Reactivity: Staphylococcus aureus

Host: Mouse

Clonality: Monoclonal

Conjugate: This Staphylococcus Aureus antibody is conjugated to Biotin

Application: Enzyme Immunoassay (EIA)

Purification: 6% PEG Precipitation.

Immunogen: UV inactivated Staphylococcus aureus (ATCC 29740).

Clone: 702

Isotype: IgG3

Application Details

Application Notes: May be used in Immunoassays to detect and quantitate Staph. aureus cells.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Concentration: 1.66 mg/mL (OD280nm, E0.1% = 1.25)

Buffer: PBS buffer, pH 7.4 without preservatives.

Preservative: Without preservative

Handling Advice: This product is photosensitive and should be protected from light

Storage: 4 °C

Storage Comment: Store at 4 °C. DO NOT FREEZE.

References for anti-Staphylococcus Aureus antibody (Biotin) (ABIN111568)

Tello, Rodríguez-Rodríguez, Yélamos, Gómez-Gutiérrez, Peterson, Gavilanes: "High-yield production of a chimeric glycoprotein based on permuted E1 and E2 HCV envelope ectodomains." in: Journal of virological methods, Vol. 213, pp. 38-44, (2015) (PubMed).

Stenholm, Hakanen, Vaarno, Pihlasalo, Terho, Hänninen, Vuopio-Varkila, Huovinen, Kotilainen: "Methicillin-resistant Staphylococcus aureus screening by online immunometric monitoring of bacterial growth under selective pressure." in: Antimicrobial agents and chemotherapy, Vol. 53, Issue 12, pp. 5088-94, (2009) (PubMed).

Schneider, Meusel, Renker, Bauer, Holzinger, Roeder, Wanner, Gekle, Sauvant: "Low-dose indomethacin after ischemic acute kidney injury prevents downregulation of Oat1/3 and improves renal outcome." in: American journal of physiology. Renal physiology, Vol. 297, Issue 6, pp. F1614-21, (2009) (PubMed).

Ramaglia, King, Nourallah, Wolterman, de Jonge, Ramkema, Vigar, van der Wetering, Morgan, Troost, Baas: "The membrane attack complex of the complement system is essential for rapid Wallerian degeneration." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 27, Issue 29, pp. 7663-72, (2007) (PubMed).

Nattermann, Nischalke, Hofmeister, Ahlenstiel, Zimmermann, Leifeld, Weiss, Sauerbruch, Spengler: "The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells." in: The American journal of pathology, Vol. 166, Issue 2, pp. 443-53, (2005) (PubMed).

Torzewski, Shaw, Han, Shortal, Lackner, Witztum, Palinski, Tsimikas: "Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 24, Issue 12, pp. 2307-12, (2004) (PubMed).

Target Details for Staphylococcus Aureus

Target: Staphylococcus Aureus

Abstract: Staphylococcus Aureus Products

Target Type: Bacteria

Background: Staphylococcus aureus are gram-positive bacteria that, although part of the normal flora of humans (nasal passages, skin and mucous membranes), have the potential to become opportunistic pathogens. S. aureus is a frequent cause of a wide range of infections and some bacterial strains have become resistant to many commonly used antibiotics.Synonyms: S. aureus